UPDATE: JP Morgan Raises PT on Centene To $39

JP Morgan has published a research report on Centene Corporation CNC after the company reported its 2Q earnings. In the report, JP Morgan writes, "Post the 2Q report, we are updating our earnings outlook. Our 2011E is unchanged at $2.20, as we offset 2Q upside with rate challenges and start-up costs for KY and LA contract awards in the back half of the year." JP Morgan maintains its Neutral rating and has raised the price target from $38 to $39. Centene Corporation closed Friday at $32.81.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareJP MorganManaged Health Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!